article thumbnail

Delivery of healthcare provider’s lifestyle advice and lifestyle behavioural change in adults who were overweight or obese in pre-diabetes management in the USA NHANES (2013–2018)

BMJ

doi: 10.1136/fmch-2021-001139 Prediabetes, a health condition with blood sugar levels higher than normal but not yet high enough to be diagnosed as type 2 diabetes, increases the risk of developing type 2 diabetes and heart disease. In the US, about 11% of people with prediabetes will progress to type 2 diabetes annually.

article thumbnail

Diabetes in Late Life: Nadine Carter, Tamryn Gray, Alex Lee

GeriPal

Summary Transcript Summary Diabetes is common. When I’m on palliative care consults and attending in our hospice unit we have to counsel patients about deprescribing and de-intensifying diabetes medications. And yet we’re also in a different place in diabetes monitoring and management. Goldilocks zone). This is Eric Widera.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Time for Geriatric Assessments in Cancer Care: William Dale, Mazie Tsang, and John Simmons

GeriPal

William: So ASCO decided to make a high priority this year to redo the guidelines, which were originally released in 2018. So they are an important part of developing a relationship where one of the manifestations clearly is, “Well, yeah, I felt good about that. The caregiver has access to these tools.

article thumbnail

8 Reasons Why Family Physicians are the Actual Stars of Medicine

Family Medicine Initiative

million people in 2018), shows that the longer you know your GP, the better off you are. This graph illustrates that the benefit of long-term GP-patient relationships is even dose-dependent (longer GP-patient-relationship = lower risk of dying prematurely): Why do long-term GP-patient relationships improve health and reduce costs?

article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

There is a lot to digest with these draft clinical guidelines but the big change from the 2018 guideline is moving Alzheimers to a biological diagnosis (biomarker evidence only) not just for a research framework but now from a clinical one. I can’t quarrel conceptually with it. Glycosylated hemoglobin is a measure of physiology.